Many epithelial cancers are associated with chronic inflammation. However, the features of inflammation that are pro- 
INTRODUCTION
producing and Treg cells following ETBF colonization suggests that Treg responses may play a role in modulating IL-17-driven immune procarcinogenesis in the colon.
Tregs promote colonic neoplasia in ETBF-colonized Min mice
We previously showed that ETBF-induced colon tumorigenesis is IL-17-dependent since injection of an anti-IL17 blocking antibody inhibited tumor formation (6) . Foxp3 + Treg function in intestinal mucosa is typically thought to suppress excessive effector immune responses to microbiota and protect the integrity of the intestinal barrier (29) (30) (31) .
Thus, we initially hypothesized that Tregs are necessary to limit ETBF-induced IL-17-mediated tumorigenesis. To assess the impact of Tregs on ETBF tumorigenesis, we crossed Min mice to Foxp3 DTR-GFP mice that express the diphtheria toxin receptor (DTR) on Foxp3 + cells (32) . Intraperitoneal administration of DT, therefore, selectively depletes Foxp3 + cells.
Because autoimmunity develops when Tregs are systemically depleted for more than two weeks (32), we tested the impact of Treg depletion on early microadenoma induction by ETBF in Min mice, which develop microadenomas in the distal colon beginning one week after ETBF colonization. This early time window (day 13) allowed us to assess the effect of Foxp3 + cells on early ETBF tumorigenesis prior to any systemic effects of Treg depletion. DT or PBS was administered
to Min x Foxp3 DTR mice starting one day prior to ETBF inoculation and every other day thereafter until harvest at day 13.
Not surprisingly, Treg-depletion significantly increased colonic inflammation ( 
Treg provide help for Th17 responses to ETBF colonization via a cell-extrinsic mechanism
Since IL-17 induction is an absolute requirement for ETBF-induced colon tumorigenesis (6) and microadenoma formation was significantly reduced in ETBF-colonized Treg-depleted mice, we asked whether Tregs in ETBF-colonized mice modified the mucosal Th1/Th17 balance in favor of protumoral Th17 effectors, potentially contributing to the development of distal colon tumorigenesis. To determine the impact of Tregs on the Th1/Th17 balance in ETBFcolonized mice, lamina propria lymphocytes (LPLs) were isolated after one week from the colons of sham or ETBFcolonized Foxp3 DTR-GFP mice treated or not with DT and analyzed for cytokine production by intracellular staining (ICS).
Indeed, in accordance with the unexpected finding that Treg depletion diminished early in situ tumor formation, depletion of Tregs in ETBF-induced colitis dramatically reduced the proportion of Th17 cells (5 +/-2%, N=5) in the colonic lamina propria compared to ETBF-colonized Treg-sufficient mice (27 +/-8%, N=5, P < 0.0001 Figure 3A and 3B). Notably, the effect of Treg depletion was not limited to Th17 cells as IL-17 production by other cell types (CD4 -) was also mitigated (Supplemental Figure 1) proportion in LPLs similar to the sham mixed BM chimera mice ( Figure 4B) . In order to determine at which point Tregs enhanced ETBF-induced Th17 responses, DT was administered one day post ETBF inoculation (late depletion), in contrast to the experiments described above in which DT was given two days prior to ETBF inoculation. In striking contrast to pre-inoculation Treg depletion, late depletion of Tregs resulted in a Th17 response that was comparable to that of Treg sufficient ETBF-colonized mice ( Figure 4C ). Taken together, these results suggest that Foxp3 + Tregs provided extrinsic support for initial Th17 differentiation, but not maintenance, in response to ETBF. Regardless of when Treg depletion was initiated (early versus late), the absence of Tregs resulted in an increased proportion of Th1 cells ( Figure   4C ).
Tregs promote Th17 development in the colon via consumption of IL-2
Tregs, which express high levels of IL-2 receptors, particularly when activated, do not produce endogenous IL-2. Thus, they are extremely dependent on exogenous sources of IL-2 for their survival. Treg proliferation and activation upon ETBF colonization may therefore deprive the local inflammatory environment of IL-2. Since IL-2 down-regulates IL-17 production via STAT5 signaling, Tregs may promote Th17 differentiation by limiting the amount of local IL-2 available to uncommitted T cells (37) (38) (39) . In contrast, IL-2 may promote proliferation of Th1 cells (40) . To determine whether Treg
Research. promotion of Th17 differentiation upon ETBF colonization occurs via limiting local IL-2, ETBF-colonized Treg-depleted Foxp3 DTR mice were injected with a blocking antibody against IL-2 (S4B6-1) and LPLs were isolated after 7 days of ETBF colonization. 
DISCUSSION
In an effort to further understand the mechanisms of ETBF-driven procarcinogenic colitis, we investigated the impact of mucosal Treg cells on the inflammatory response to ETBF murine colonization. These studies led to the surprising conclusion that Tregs are critical to initiate the Th17 colitis necessary for tumor induction. Through consumption of IL-2,
Tregs inhibit the development of Th1 colitis, which is not procarcinogenic, and shift T cell differentiation to Th17 in the Recent reports showed that mucosal Tregs, which commonly orchestrate mucosal immune homeostasis by restraining inflammatory responses to microbiota in the gut, can cooperate with immune effector cells to protect against and eradicate infections (27, 38). Th17 cells, by their production of IL-17, are predicted to be important to the mucosal defense against ETBF, resulting in the recruitment of bactericidal polymorphonuclear and phagocytic mononuclear cells.
Consistent with this idea, IL-17
-/-mice colonized with ETBF exhibit increased morbidity and mortality compared to wildtype mice (C Dejea, C Sears, unpublished). However, the mucosal Th17 defenses against ETBF are not antiseptic and thus do not prevent chronic colitis associated with the persistence of both ETBF and mucosal IL-17 production (22) . In conjunction with a host genetic predisposition, such as the Apc mutation in Min mice, ETBF-induced mucosal IL-17 is instrumental in promoting marked distal colon tumorigenesis (6) . Importantly, a predominant IL-17 response is associated with worse survival in human CRC (11) . ETBF represents the first common human commensal identified as a potent trigger for murine colon tumorigenesis (6, 19) . Surprisingly, ETBF triggers its carcinogenic IL-17 response, in part, murine model of oral Candida albicans that poorly suppressive Tregs were important to initiate the anti-fungal Th17 response, but they eventually resumed their suppressive function and inhibited pathogenic Th17 effectors (38 Treg depletion is not surprising, especially in the gut where there is constant exposure to inflammatory stimuli such as pathogen-associated molecular patterns on commensal bacteria. In fact, Treg cell depletion has recently been shown to increase the inflammatory cytokines IFN-γ and IL-17 in the intestines (24) , and adoptive transfer of Treg cells can cure experimental models of inflammatory bowel disease (26, 55) . These data emphasize that Tregs exercise strong immunosuppressive function on effector T cells in other settings. However, in ETBF colonization, mucosal Tregs polarize a robust IL-17 mucosal immunity while suppressing Th1 immunity. We noted that the inflammation score one week following ETBF colonization, in contrast to inflammation following 13 days ETBF, remained similar with or without Tregs; however, the character of this inflammation differed, with Tregs promoting IL-17 while repressing IFN-γ.
Our findings allow a better understanding of the Th17 polarization induced by ETBF colonization and its contribution to colon tumorigenesis. However, the cellular and molecular mechanisms by which ETBF selectively increases Tregs in the distal murine colon remain unknown. As BFT, which profoundly alters the biology of colonic epithelial cells (23), is required for ETBF-driven oncogenic IL-17 production, we postulate that epithelial-derived signals,
Research. 
METHODS

Mice and reagents
C57BL/6 Foxp3
DTR-GFP mice were provided by A. Rudensky (Memorial Sloan-Kettering Cancer Center, New York, New York). C57BL/6 Rag1 -/-, CD45.1, and IFN-γ -/-mice were purchased from Jackson Laboratories (Bar Harbor, ME). Apc 
ETBF mouse models
ETBF strain 86-5443-2-2 was used in this study (6, 21) . B. fragilis strains were grown anaerobically on BHI medium plates containing 37 g of brain heart infusion base (Difco Laboratories week old mice were treated with clindamycin and streptomycin (0.1 g/L and 5 g/L, respectively, in water bottles) 5 days prior to ETBF inoculation by gavage (~10 8 bacteria in PBS). BM chimera mice were inoculated with ETBF 6 weeks after sub-lethal irradiation. All strains are resistant to these antibiotic treatments. Mice were sacrificed 7 days after colonization, unless otherwise noted.
Treg depletion and IL-2 neutralization
Mice received 50 ng intraperitoneal (ip) injections of diphtheria toxin (DT; Sigma-Aldrich, MO) per g body weight on days one and two prior to ETBF inoculation (D-2, D-1) and on days 1, 3 and 5 after ETBF inoculation (D+1, D+3, D+5).
Colons were harvested from mice 7 days after ETBF inoculation. In some experiments, IL-2 was neutralized by ip injection of 0.5 mg/mouse of anti-IL-2 mAb (clone S4B6) or isotype control (rat IgG2a) 2 days prior and every day after ETBF inoculation until mouse sacrifice. For tumor experiments, mice received 50 ng DT per g body weight on D-1, D0, D+1, D+3, and every other day until sacrifice and harvest on D+13.
Lamina propria lymphocytes (LPL) isolation
Dissected colons were flushed with 20 ml Ca 2+ , Mg 2+ free PBS 1X and cut longitudinally. Tissues were cut in <0. 
Flow cytometry and fluorescence-associated cell sorting (FACS)
Colons from 1-2 mice per group were processed to obtain lamina propria lymphocytes (LPLs) as previously described (59). Mononuclear cells collected by Percoll gradient separation were cultured 4hr in Iscove's Modified Dulbecco's Medium (IMDM) with 5% FCS and in the presence of Cell Stimulation Cocktail (plus protein transport inhibitors) (eBioscience). Cells were then washed and stained for cell surface markers followed by fixation and permeabilization (Foxp3 Fixation buffer, eBioscience). ICS was performed for IFN-γ, IL-17A and Foxp3. Flow cytometry acquisition was performed on LSRII cytometer (BD Bioscience) and data was analyzed using FACSDiva 6.1.3 software. In some experiments, FACS was performed on FACSAria II (BD Bioscience).
Quantitative RT-PCR
Total RNA was isolated from sorted cells or whole tissue using TRIzol® reagent from Life Technologies (Grand Island, NY) according to manufacturer's instructions. 1μg of RNA was reverse transcribed using High-Capacity RNA-tocDNA™ Kit (Applied Biosystems®). 40 cycles of TaqMan® Gene Expression qRT-PCR was performed on 1 ng RNA per sample for indicated genes. ^Ct was calculated by subtracting Ct of Gapdh from Ct of target gene and averaging 2 technical replicates.
Histology and microadenoma counts
Colons were dissected and preserved in 10% buffered formalin. Histologic examination was performed after hematoxylin and eosin (H&E) staining of 5 μm sections. To facilitate longitudinal examination of the full-length colon, colons were 'Swiss-rolled' prior to embedding and sectioning. Total colon inflammation was scored as previously described (21) .
Microadenoma counts on formalin-fixed paraffin-embedded H&E colon tissue sections from 2-week ETBF-colonized Min mice, and all histopathology scoring, were performed by a pathologist (DH).
Statistical analysis
Research. Comparison of means was done by unpaired, two-tailed Mann-Whitney U testing, unless otherwise indicated. A p value of ≤ 0.05 was considered to designate a significant difference.
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